A growing body of evidence also suggests that the accumulation of misfolding proteins in AD is caused by damage to macromolecular autophagy and autophagy lysosomal pathways, making TFEB, which regulates autophagic lysosomal pathway, a promising target for AD treatment (Zheng et al., 2021). This evidence concerns the gene TFEB and Alzheimer disease.